Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9

被引:0
|
作者
Shenzhao Lu
Jiawei Zhou
机构
[1] Chinese Academy of Sciences,Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences
来源
Neuroscience Bulletin | 2017年 / 33卷
关键词
Parkinson’s disease; Genetic variant; CRISPR/Cas9;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide, but its cause and pathogenesis are still not fully understood. Earlier studies have shown that SNCA, which encodes α-synuclein, is one of the key genes associated with PD. Single-nucleotide polymorphism (SNP) variants of SNCA are thought to be correlated with disease onset. The underlying mechanisms however are enigmatic. A recent study published in Nature revealed that one of the SNP variants in the SNCA non-coding element elevated α-synuclein expression in human neurons by reducing the binding efficiency of transcription factors, demonstrating a previously uncharted role for SNPs in the pathogenesis of PD.
引用
收藏
页码:115 / 117
页数:2
相关论文
共 50 条
  • [1] Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9
    Lu, Shenzhao
    Zhou, Jiawei
    NEUROSCIENCE BULLETIN, 2017, 33 (01) : 115 - 117
  • [2] Finding the ‘Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9
    Shenzhao Lu
    Jiawei Zhou
    Neuroscience Bulletin, 2017, (01) : 115 - 117
  • [3] Application of CRISPR/Cas9 in the management of Alzheimer's disease and Parkinson's disease: a review
    Thapar, Nandita
    Eid, Mosab Ahmad Fathi
    Raj, Nishchita
    Kantas, Theodosios
    Billing, Harbir S.
    Sadhu, Dhavalkumar
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (01): : 329 - 335
  • [4] CRISPR/Cas9 gene editing: New hope for Alzheimer's disease therapeutics
    Bhardwaj, Shanu
    Kesari, Kavindra Kumar
    Rachamalla, Mahesh
    Mani, Shalini
    Ashraf, Ghulam Md
    Jha, Saurabh Kumar
    Kumar, Pravir
    Ambasta, Rashmi K.
    Dureja, Harish
    Devkota, Hari Prasad
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Singh, Sachin Kumar
    Dua, Kamal
    Ruokolainen, Janne
    Kamal, Mohammad Amjad
    Ojha, Shreesh
    Jha, Niraj Kumar
    JOURNAL OF ADVANCED RESEARCH, 2022, 40 : 207 - 221
  • [5] Application of CRISPR/Cas9 in Alzheimer's Disease
    Lu, Likui
    Yu, Xi
    Cai, Yongle
    Sun, Miao
    Yang, Hao
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [6] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [7] CRISPR/Cas9 Edited sRAGE-MSCs Protect Neuronal Death in Parkinson's Disease Model
    Lee, Aesuk
    Bayarsaikhan, Delger
    Arivazhagan, Roshini
    Park, Hyejung
    Lim, Byungyoon
    Gwak, Peter
    Jeong, Goo-Bo
    Lee, Jaewon
    Byun, Kyunghee
    Lee, Bonghee
    INTERNATIONAL JOURNAL OF STEM CELLS, 2019, 12 (01) : 114 - +
  • [8] Deletion of a target gene in Indica rice via CRISPR/Cas9
    Ying Wang
    Lizhao Geng
    Menglong Yuan
    Juan Wei
    Chen Jin
    Min Li
    Kun Yu
    Ya Zhang
    Huaibing Jin
    Eric Wang
    Zhijian Chai
    Xiangdong Fu
    Xianggan Li
    Plant Cell Reports, 2017, 36 : 1333 - 1343
  • [9] Deletion of a target gene in Indica rice via CRISPR/Cas9
    Wang, Ying
    Geng, Lizhao
    Yuan, Menglong
    Wei, Juan
    Jin, Chen
    Li, Min
    Yu, Kun
    Zhang, Ya
    Jin, Huaibing
    Wang, Eric
    Chai, Zhijian
    Fu, Xiangdong
    Li, Xianggan
    PLANT CELL REPORTS, 2017, 36 (08) : 1333 - 1343
  • [10] Modeling Disease In Vivo With CRISPR/Cas9
    Dow, Lukas E.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (10) : 609 - 621